Our data indicate that our centenarian iPSCs and FAD- and PARK4-iPSCs are suitable for use in neurodegenerative disease research, especially with respect to β-amyloidopathy and α-synucleinopathy, and that these cells could serve as valid super-controls for use in studies of other late-onset diseases. Here, SNCA is linked to synucleinopathy.